These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 29559554)

  • 21. Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo.
    Drgon T; Lin Z; Wang GJ; Fowler J; Pablo J; Mash DC; Volkow N; Uhl GR
    Cell Mol Neurobiol; 2006; 26(4-6):875-89. PubMed ID: 16710758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infantile parkinsonism-dystonia: a dopamine "transportopathy".
    Blackstone C
    J Clin Invest; 2009 Jun; 119(6):1455-8. PubMed ID: 19504720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leaky lessons learned: Efflux prone dopamine transporter variant reveals sex and circuit specific contributions of D2 receptor signalling to neuropsychiatric disease.
    Mayer FP; Stewart A; Blakely RD
    Basic Clin Pharmacol Toxicol; 2024 Feb; 134(2):206-218. PubMed ID: 37987120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human dopamine transporter gene variation: effects of protein coding variants V55A and V382A on expression and uptake activities.
    Lin Z; Uhl GR
    Pharmacogenomics J; 2003; 3(3):159-68. PubMed ID: 12815364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dopamine transporter gene SLC6A3: multidisease risks.
    Reith MEA; Kortagere S; Wiers CE; Sun H; Kurian MA; Galli A; Volkow ND; Lin Z
    Mol Psychiatry; 2022 Feb; 27(2):1031-1046. PubMed ID: 34650206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention-deficit hyperactivity disorder in adults: A systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies.
    Bonvicini C; Faraone SV; Scassellati C
    Mol Psychiatry; 2016 Jul; 21(7):872-84. PubMed ID: 27217152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.
    Bowton E; Saunders C; Erreger K; Sakrikar D; Matthies HJ; Sen N; Jessen T; Colbran RJ; Caron MG; Javitch JA; Blakely RD; Galli A
    J Neurosci; 2010 Apr; 30(17):6048-57. PubMed ID: 20427663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs.
    Johansson S; Halleland H; Halmøy A; Jacobsen KK; Landaas ET; Dramsdahl M; Fasmer OB; Bergsholm P; Lundervold AJ; Gillberg C; Hugdahl K; Knappskog PM; Haavik J
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1470-5. PubMed ID: 18081165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.
    Dehnes Y; Shan J; Beuming T; Shi L; Weinstein H; Javitch JA
    Neurochem Int; 2014 Jul; 73():4-15. PubMed ID: 24576496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies.
    Costa A; Riedel M; Müller U; Möller HJ; Ettinger U
    Synapse; 2011 Oct; 65(10):998-1005. PubMed ID: 21404331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD).
    Oades RD
    Prog Brain Res; 2008; 172():543-65. PubMed ID: 18772050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.
    Greenwood TA; Joo EJ; Shekhtman T; Sadovnick AD; Remick RA; Keck PE; McElroy SL; Kelsoe JR
    Am J Med Genet B Neuropsychiatr Genet; 2013 Mar; 162B(2):137-45. PubMed ID: 23255304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
    Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
    J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
    Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD.
    Bellgrove MA; Barry E; Johnson KA; Cox M; Dáibhis A; Daly M; Hawi Z; Lambert D; Fitzgerald M; McNicholas F; Robertson IH; Gill M; Kirley A
    Neuropsychopharmacology; 2008 Sep; 33(10):2536-45. PubMed ID: 18046306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reward-enhancing effect of methylphenidate is abolished in dopamine transporter knockout mice: A model of attention-deficit/hyperactivity disorder.
    Ide S; Ikekubo Y; Hua J; Takamatsu Y; Uhl GR; Sora I; Ikeda K
    Neuropsychopharmacol Rep; 2018 Sep; 38(3):149-153. PubMed ID: 30175528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine-mediated immunomodulation affects choroid plexus function.
    Castellani G; Contarini G; Mereu M; Albanesi E; Devroye C; D'Amore C; Ferretti V; De Martin S; Papaleo F
    Brain Behav Immun; 2019 Oct; 81():138-150. PubMed ID: 31175999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional coding variation in the presynaptic dopamine transporter associated with neuropsychiatric disorders drives enhanced motivation and context-dependent impulsivity in mice.
    Davis GL; Stewart A; Stanwood GD; Gowrishankar R; Hahn MK; Blakely RD
    Behav Brain Res; 2018 Jan; 337():61-69. PubMed ID: 28964912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia.
    Kurian MA; Zhen J; Cheng SY; Li Y; Mordekar SR; Jardine P; Morgan NV; Meyer E; Tee L; Pasha S; Wassmer E; Heales SJ; Gissen P; Reith ME; Maher ER
    J Clin Invest; 2009 Jun; 119(6):1595-603. PubMed ID: 19478460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state of transporter inactivation associated with Val382Ala.
    Mazei-Robison MS; Blakely RD
    Neuropharmacology; 2005 Nov; 49(6):737-49. PubMed ID: 16212992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.